Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 04, 2025

Get In Touch

Abdominal Obesity Tied To More Than 4-Fold Risk Of Coronary Artery Calcification In CKD Patients: Study Nephrology

Abdominal Obesity Tied To More Than 4-Fold Risk Of Coronary Artery Calcification In CKD Patients: Study

  • 30 July 2025
  • 3 months ago

Physical Activity Decreases CVD Mortality In Patients On Dialysis: Study Nephrology

Physical Activity Decreases CVD Mortality In Patients On Dialysis: Study

  • 30 July 2025
  • 3 months ago

Postoperative Intravesical Gentamicin Fails To Significant Impact Postoperative UTI Treatment Urology

Postoperative Intravesical Gentamicin Fails To Significant Impact Postoperative UTI Treatment

  • 30 July 2025
  • 3 months ago

Triple Immunosuppression Helps Decrease Proteinuria In Lupus Nephritis Urology

Triple Immunosuppression Helps Decrease Proteinuria In Lupus Nephritis

  • 30 July 2025
  • 3 months ago

Prediabetes Treatment May Reduce Heart And Kidney Risks In Childhood Cancer Survivors Nephrology

Prediabetes Treatment May Reduce Heart And Kidney Risks In Childhood Cancer Survivors

  • 30 July 2025
  • 3 months ago

Reduced Kidney Function Increases Bleeding Risk In Antithrombotic Therapy Nephrology

Reduced Kidney Function Increases Bleeding Risk In Antithrombotic Therapy

  • 30 July 2025
  • 3 months ago

Canagliflozin Reduces Anemia Risk In Patients With CKD And Diabetes: Lancet Nephrology

Canagliflozin Reduces Anemia Risk In Patients With CKD And Diabetes: Lancet

  • 30 July 2025
  • 3 months ago

Semaglutide Reduces Risk Of Major Kidney Events And Death From CV Causes Among Diabetes Patients With CKD: NEJM Nephrology

Semaglutide Reduces Risk Of Major Kidney Events And Death From CV Causes Among Diabetes Patients With CKD: NEJM

  • 30 July 2025
  • 3 months ago

Depression Hastens Nephropathy Progression In Type 1 Diabetes: Study Nephrology

Depression Hastens Nephropathy Progression In Type 1 Diabetes: Study

  • 30 July 2025
  • 3 months ago

Mineralocorticoid Receptor Antagonists Reduce Risk Of All-Cause Mortality And CV Death In ESRD Patients Nephrology

Mineralocorticoid Receptor Antagonists Reduce Risk Of All-Cause Mortality And CV Death In ESRD Patients

  • 30 July 2025
  • 3 months ago

Recent News

Nanotechnology Reverses Alzheimer's Symptoms in Mi...

  • 03 November, 2025

Gum disease could silently cause serious brain dam...

  • 03 November, 2025

Can Early-Day Fasting Significantly Boost Metaboli...

  • 03 November, 2025

Delhi HC bars doctor from running medical centre d...

  • 03 November, 2025

Phase III data for Gazyva/Gazyvaro show significan...

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.